Industry Report – February 2026

The Industry Report in reply-all shares a selection of recent news featuring UPMC Enterprises, our portfolio companies, and partnerships.

This edition includes stories about our investment in Precede Biosciences, Ouro Medicine’s FDA fast track designation, RxAnte’s strategic growth investment from Primus Capital, and biopharma insights from Matthias Kleinz in an interview with MedCity News.

Keep an eye on UPMC Enterprises’ News webpage for the latest industry stories.

UPMC Enterprises 

Avista Therapeutics

BrainCheck  

Butterfly Network

Carta Healthcare

Ouro Medicines

Precede Biosciences

sovaSage

RxAnte

Sempre Health

Penguin Ai 

You Might Also Like…

More From the Newsletter